Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedQiryat Krinitzi, Israel, 5265601 was removed and Tel Litwinsky, Israel, 5265601 was added as recruitment sites.SummaryDifference0.1%

- Check8 days agoChange DetectedThe study's location list was updated to add Qiryat Krinitzi, Israel, 5265601 and remove Tel Litwinsky, Israel, 5265601, and the page revision was updated to v3.6.6.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision label has been updated to v3.6.5, representing a new revision in the publication's history.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, representing a minor software or CMS update rather than content changes on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedSteatotic Liver Disease is now listed as an additional relevant MeSH term and Fatty Liver Disease was removed from the related terms. This update changes the page's disease terminology for indexing and discoverability without altering study details.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page shows Revision: v3.6.3, replacing the earlier v3.6.2. This reflects a small update to the page’s metadata rather than a change to core content.SummaryDifference0.0%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.